Direct Nasal Cavity Introduction
Rich Vascular Network
Avoidance of First-Pass Metabolism
Uniform Distribution
Direct Nasal Cavity Introduction
Rich Vascular Network
Avoidance of First-Pass Metabolism
Uniform Distribution
Please note this resource does not constitute medical advice. Patients are encouraged to seek advice from their prescribing clinician.
LTR Pharma is dedicated to facilitating supportive, open and educational conversations about the lived experiences and treatment options available for people experiencing erectile dysfunction (ED).
This video series - delivered in partnership with LTR Pharma Scientific and Clinical Advisor and consultant urological surgeon, Professor Eric Chung - is part of ongoing efforts to engage with the medical community.
In this six-part Q&A series, Professor Chung shares insights into male sexual dysfunction; his widespread clinical observations and experiences with regards to ED; the scientific insights and evidence into the treatment landscape; the many myths and misconceptions surrounding ED; his professional involvement with LTR Pharma; and wider industry views towards our innovative SPONTAN® (vardenafil HCL nasal spray) technology.